- Home
- SCD vs VNDA Comparison
SCD vs VNDA Comparison
Compare SCD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCD
- VNDA
- Stock Information
- Founded
- SCD 2003
- VNDA 2002
- Country
- SCD United States
- VNDA United States
- Employees
- SCD N/A
- VNDA N/A
- Industry
- SCD Trusts Except Educational Religious and Charitable
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- SCD Finance
- VNDA Health Care
- Exchange
- SCD Nasdaq
- VNDA Nasdaq
- Market Cap
- SCD 248.0M
- VNDA 237.9M
- IPO Year
- SCD N/A
- VNDA 2006
- Fundamental
- Price
- SCD $16.12
- VNDA $4.34
- Analyst Decision
- SCD
- VNDA Strong Buy
- Analyst Count
- SCD 0
- VNDA 3
- Target Price
- SCD N/A
- VNDA $15.33
- AVG Volume (30 Days)
- SCD 62.6K
- VNDA 519.0K
- Earning Date
- SCD 01-01-0001
- VNDA 05-07-2025
- Dividend Yield
- SCD 9.63%
- VNDA N/A
- EPS Growth
- SCD N/A
- VNDA N/A
- EPS
- SCD N/A
- VNDA N/A
- Revenue
- SCD N/A
- VNDA $201,351,000.00
- Revenue This Year
- SCD N/A
- VNDA $16.86
- Revenue Next Year
- SCD N/A
- VNDA $39.78
- P/E Ratio
- SCD N/A
- VNDA N/A
- Revenue Growth
- SCD N/A
- VNDA 13.37
- 52 Week Low
- SCD $11.33
- VNDA $3.81
- 52 Week High
- SCD $15.87
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- SCD 63.98
- VNDA 51.79
- Support Level
- SCD $15.49
- VNDA $4.17
- Resistance Level
- SCD $15.99
- VNDA $4.41
- Average True Range (ATR)
- SCD 0.28
- VNDA 0.16
- MACD
- SCD 0.03
- VNDA 0.03
- Stochastic Oscillator
- SCD 92.86
- VNDA 73.61
About SCD LMP Capital and Income Fund Inc.
Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.